A new look at the neuronal nicotinic acetylcholine receptor pharmacophore

European Journal of Pharmacology

Volumn 393, Issue 1-3, 2000, Pages 155-163

  Curtis, Logos ^a   Chiodini, Florence ^a   Spang, Jörg E ^b,c   Bertrand, Sonia ^a   Patt, Jörg T ^b,c   Westera, Gerrit ^b,c   Bertrand, Daniel ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Acetylcholine receptor; Ligand binding domain; Neuron; Pharmacological; Physiological; Property

Indexed keywords

ACETYLCHOLINE; CYTISINE; EPIBATIDINE; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ANIMAL CELL; BINDING SITE; CONFERENCE PAPER; CONTROLLED STUDY; ENANTIOMER; FROG; HUMAN; IN VITRO STUDY; LIGAND BINDING; MUTATION; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECEPTOR BINDING;

ACETYLCHOLINE; ALLOSTERIC REGULATION; AMINO ACID SEQUENCE; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING, COMPETITIVE; ELECTROPHYSIOLOGY; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; NEURONS; NICOTINIC AGONISTS; POLYMERASE CHAIN REACTION; PYRIDINES; RATS; RECEPTORS, NICOTINIC; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION; XENOPUS;

EID: 0034732115     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00053-4     Document Type: Conference Paper

References (33)

1. Adler L.E., Freedman R., Ross R.G., Olincy A., Waldo M.C. Elementary phenotypes in the neurobiological and genetic study of schizophrenia. Biol. Psychiatry. 46:1999;8-18.
2. Bannon A.W., Decker M.W., Holladay M.W., Curzon P., Donnelly-Roberts D., Puttfarcken P.S., Bitner R.S., Diaz A., Dickenson A.H., Porsolt R.D., Williams M., Arneric S.P. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science. 279:1998;77-81.
3. Bertrand D. Neuronal nicotinic acetylcholine receptors: their properties and alterations in autosomal dominant nocturnal frontal lobe epilepsy. Rev. Neurol. (Paris). 155:1999;457-462.
4. Bertrand D., Changeux J.P. Nicotinic receptor: an allosteric protein specialized for intercellular communication. Semin. Neurosci. 7:1995;75-90.
5. Bertrand D., Cooper E., Valera S., Rungger D., Ballivet M. Conn M. Electrophysiology of Neuronal Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes Following Nuclear Injection of Genes or cDNAs. Vol. 4:1991;174-193 Academic Press, New York.
6. Bertrand S., Patt J.T., Spang J.E., Westera G., Schubiger P.A., Bertrand D. Neuronal nAChR stereoselectivity to non-natural epibatidine derivatives. FEBS Lett. 450:1999;273-279.
7. Changeux J.P., Edelstein S.J. Allosteric receptors after 30 years. Neuron. 21:1998;959-980.
8. Chavez-Noriega L.E., Crona J.H., Washburn M.S., Urrutia A., Elliott K.J., Johnson E.C. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 280:1997;346-356.
9. Coggan J.S., Paysan J., Conroy W.G., Berg D.K. Direct recording of nicotinic responses in presynaptic nerve terminals. J. Neurosci. 17:1997;5798-5806.
10. Couturier S., Erkman L., Valera S., Rungger D., Bertrand S., Boulter J., Ballivet M., Bertrand D. Alpha 5, alpha 3, and non-alpha 3. Three clustered avian genes encoding neuronal nicotinic acetylcholine receptor-related subunits. J. Biol. Chem. 265:1990;17560-17567.
11. Daly J.W. Thirty years of discovering arthropod alkaloids in amphibian skin. J. Nat. Prod. 61:1998;162-172.
12. Devillers-Thiéry A., Galzi J.L., Bertrand S., Changeux J.P., Bertrand D. Stratified organization of the nicotinic acetylcholine receptor channel. NeuroReport. 3:1992;1001-1004.
13. Edelstein S.J., Schaad O., Henry E., Bertrand D., Changeux J.P. A kinetic mechanism for nicotinic acetylcholine receptors based on multiple allosteric transitions. Biol. Cybern. 75:1996;361-379.
14. Eiselé J.L., Bertrand S., Galzi J.L., Devillers T.A., Changeux J.P., Bertrand D. Chimaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities. Nature. 366:1993;479-483.
15. Galzi J.L., Edelstein S.J., Changeux J.P. The multiple phenotypes of allosteric receptor mutants. Proc. Natl. Acad. Sci., U.S.A. 93:1996;1853-1858.
16. Giraudat J., Galzi J.L., Revah F., Changeux J.P., Haumont P.Y., Lederer F. The noncompetitive blocker chlorpromazine labels segment MII but not segment MI on the nicotinic acetylcholine receptor alpha-subunit. FEBS Lett. 253:1989;190-198.
17. Gross A., Ballivet M., Rungger D., Bertrand D. Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes: role of the alpha subunit in agonist sensitivity and desensitization. Pflugers Arch. 419:1991;545-551.
18. Grutter T., Goeldner M., Kotzyba-Hibert F. Nicotinic acetylcholine receptor probed with a photoactivatable agonist: improved labeling specificity by addition of CeIV/glutathione. Extension to laser flash photolabeling. Biochemistry. 38:1999;7476-7484.
19. Holladay M.W., Bai H., Li Y., Lin N.H., Daanen J.F., Ryther K.B., Wasicak J.T., Kincaid J.F., He Y., Hettinger A.M., Huang P., Anderson D.J., Bannon A.W., Buckley M.J., Campbell J.E., Donnelly-Roberts D.L., Gunther K.L., Kim D.J., Kuntzweiler T.A., Sullivan J.P., Decker M.W., Arneric S.P. Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice. Bioorg. Med. Chem. Lett. 8:1998;2797-2802.
20. Horton R.M., Hunt H.D., Ho S.N., Pullen J.K., Pease L.R. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 77:1989;61-68.
21. Hucho F., Oberthür W., Lottspeich F. The ion channel of the nicotinic acetylcholine receptor is formed by the homologous helices M2 of the receptor subunits. FEBS Lett. 205:1986;137-142.
22. Lemiere J., Van Gool D., Dom R. Treatment of Alzheimer's disease: an evaluation of the cholinergic approach. Acta Neurol. Belg. 99:1999;96-106.
23. Léna C., Changeux J., Mulle C. Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. J. Neurosci. 13:1993;2680-2688.
24. McGehee D.S., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57:1995;521-546.
25. Miyazawa A., Fujiyoshi Y., Stowell M., Unwin N. Nicotinic acetylcholine receptor at 4.6 A resolution: transverse tunnels in the channel wall. J. Mol. Biol. 288:1999;765-786.
26. Patt J.T., Spang J.E., Westera G., Buck A., Schubiger P.A. Synthesis and in vivo studies of [C-11]N-methylepibatidine: comparison of the stereoisomers. Nucl. Med. Biol. 26:1999;165-173.
27. Perry E., Walker M., Grace J., Perry R. Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci. 22:1999;273-280.
28. Potter A., Corwin J., Lang J., Piasecki M., Lenox R., Newhouse P.A. Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease. Psychopharmacology (Berlin). 142:1999;334-342.
29. Sanberg P.R., Silver A.A., Shytle R.D., Philipp M.K., Cahill D.W., Fogelson H.M., Mcconville B.J. Nicotine for the treatment of Tourette's syndrome. Pharmacol. Ther. 74:1997;21-25.
30. Shoop R.D., Martone M.E., Yamada N., Ellisman M.H., Berg D.K. Neuronal acetylcholine receptors with alpha7 subunits are concentrated on somatic spines for synaptic signaling in embryonic chick ciliary ganglia. J. Neurosci. 19:1999;692-704.
31. Spang J.E., Patt J.T., Bertrand S., Bertrand D., Westera G., Schubiger P.A. Synthesis and electrophysiological studies of a novel epibatidine analogue. J. Recept. Signal Transduction Res. 19:1999;521-531.
32. Steinlein O.K., Magnusson A., Stoodt J., Bertrand S., Weiland S., Berkovic S.F., Nakken K.O., Propping P., Bertrand D. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum. Mol. Genet. 6:1997;943-947.
33. White H.K., Levin E.D. Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. Psychopharmacology (Berlin). 143:1999;158-165.